Search

Author/Creator Schnadig, Ian

1. A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. Issue 4 (April 2015)

Authors:
Jimeno, Antonio; Bauman, Julie E.; Weissman, Charles; Adkins, Douglas; Schnadig, Ian; Beauregard, Patrice; Bowles, Daniel W.; Spira, Alexander; Levy, Benjamin; Seetharamu, Nagashree; Hausman, Diana; Walker, Luke; Rudin, Charles M.; Shirai, Keisuke
Journal:
Oral oncology
Issue:
Volume 51:Issue 4(2015:Apr.)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Issue 2 (February 2022)

Authors:
Siefker-Radtke, Arlene O; Necchi, Andrea; Park, Se Hoon; García-Donas, Jesús; Huddart, Robert A; Burgess, Earle F; Fleming, Mark T; Rezazadeh Kalebasty, Arash; Mellado, Begoña; Varlamov, Sergei; Joshi, Monika; Duran, Ignacio; Tagawa, Scott T; Zakharia, Yousef; Akapame, Sydney; Santiago-Walker, Ad...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 2(2022)
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗